Opinion Statement Human immunodeficiency virus (HIV) infection is an established risk
factor for low bone mineral density (BMD) and subsequent fracture, and treatment with …

To date, the prevalence and squeal of metabolic bone diseases in RLS are poorly
described. This review highlights important gaps in our knowledge about HIV-associated …

Objectives HIV infection is associated with a higher prevalence of low bone mineral density
(BMD) and fractures than that found in the general population. There are limited data in HIV …

Background This study set out to determine the prevalence of low bone mass following long-
term exposure to antiretroviral therapy in Ugandan people living with HIV. Methods A cross …

HIV infection and initiation of antiretroviral therapy (ART) have been consistently associated
with decreased bone mineral density (BMD), with growing evidence linking HIV to an …

Results The major HIV-1 subtype detected in this study was CRF01_AE (94.5%).
Recombinant viruses containing CRF01_AE and subtype B genes (5.5%) were also …

Bone loss and vitamin D deficiency are common in HIV patients. However, bone health
status in newly diagnosed HIV patients has not been thoroughly described. Our aim was to …

Background Nucleoside reverse transcriptase inhibitors (NRTIs) are the cornerstone of
highly active antiretroviral therapy combination regimens for HIV infection. Unfortunately …

There are limited studies regarding bone health among people living with HIV (PLHIV) in
Asia. We compared bone mineral density (BMD), serum 25-hydroxyvitamin D (25 (OH) D) …

Aims: To evaluate the prevalence and associated factors of reduced bone mineral density
(BMD) among antiretroviral therapy (ART) naive HIV-infected male patients in China …